Abstract: An aspiration device is described, including a bulb aspirator including a bulb body, a first collar and tip, the bulb body includes an upper portion configured for receiving one end of the first collar and lower portion configured for receiving in a first configuration a stop and in a second different configuration a second collar associated with a suction tube, the tip is configured for insertion into a passageway; the stop being configured for detachable connection to the lower portion of the bulb body when in the first configuration; and the suction tube including the second collar, a tube portion and an adaptor, the second collar is disposed at a first end of the suction tube and being adapted to be coupled to the lower portion of the bulb body, the adaptor is configured to adapt to a human mouth to enable suction to be applied at the adaptor.

Abstract: An aspiration device is described, including a bulb aspirator including a bulb body, a first collar and tip, the bulb body includes an upper portion configured for receiving one end of the first collar and lower portion configured for receiving in a first configuration a stop and in a second different configuration a second collar associated with a suction tube, the tip is configured for insertion into a passageway; the stop being configured for detachable connection to the lower portion of the bulb body when in the first configuration; and the suction tube including the second collar, a tube portion and an adaptor, the second collar is disposed at a first end of the suction tube and being adapted to be coupled to the lower portion of the bulb body, the adaptor is configured to adapt to a human mouth to enable suction to be applied at the adaptor.

Abstract: An aspiration device is described, including a bulb aspirator including a bulb body, a first collar and tip, the bulb body includes an upper portion configured for receiving one end of the first collar and lower portion configured for receiving in a first configuration a stop and in a second different configuration a second collar associated with a suction tube, the tip is configured for insertion into a passageway; the stop being configured for detachable connection to the lower portion of the bulb body when in the first configuration; and the suction tube including the second collar, a tube portion and an adaptor, the second collar is disposed at a first end of the suction tube and being adapted to be coupled to the lower portion of the bulb body, the adaptor is configured to adapt to a human mouth to enable suction to be applied at the adaptor.

Abstract: An aspiration device is described, including a bulb aspirator including a bulb body, a first collar and tip, the bulb body includes an upper portion configured for receiving one end of the first collar and lower portion configured for receiving in a first configuration a stop and in a second different configuration a second collar associated with a suction tube, the tip is configured for insertion into a passageway; the stop being configured for detachable connection to the lower portion of the bulb body when in the first configuration; and the suction tube including the second collar, a tube portion and an adaptor, the second collar is disposed at a first end of the suction tube and being adapted to be coupled to the lower portion of the bulb body, the adaptor is configured to adapt to a human mouth to enable suction to be applied at the adaptor.

Abstract: The invention discloses a stable intravenous Propofol oil-in-water emulsion composition having mixed preservatives of low toxicity that is capable of withstanding accidental contamination of bacteria and fungi. The preservative system employed comprising of monoglyceryl ester of lauric acid (Monolaurin) and a member selected from (a) capric acid and/or its soluble alkaline salts or its monoglyceryl ester (Monocaprin); (b) edetate; and (c) capric acid and/or its soluble alkaline salts or its monoglyceryl ester (Monocaprin) and edetate.

Abstract: A low toxicity, stable oxazaphosphorine containing compositions with mesna for parenteral administration has been described. The process essentially requires addition of an oxazaphosphorine antineoplastic to the aqueous solution of an etherified ?-cyclodextrin followed by addition of mesna as such or as an aqueous solution containing optionally, an etherified ?-cyclodextrin. Preferably, the oxazaphosphorine antineoplastic is Ifosfamide and the etherified ?-cyclodextrin is 2-hydroxypropyl-?-cyclodextrin.

Abstract: The present invention provides a long circulating non-pegylated liposomal doxorubicin hydrochloride composition for parenteral administration and a process for its preparation. The circulation time in Swiss albino mice is at least 25 times longer than conventional non-liposomal formulations. The non-pegylated liposomes are stable, exhibit low toxicity and have been found to be efficacious in different tumor models.